These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37346977)

  • 1. Lipid nanoparticle delivery limits antisense oligonucleotide activity and cellular distribution in the brain after intracerebroventricular injection.
    Byrnes AE; Dominguez SL; Yen CW; Laufer BI; Foreman O; Reichelt M; Lin H; Sagolla M; Hötzel K; Ngu H; Soendergaard C; Estevez A; Lin HC; Goyon A; Bian J; Lin J; Hinz FI; Friedman BA; Easton A; Hoogenraad CC
    Mol Ther Nucleic Acids; 2023 Jun; 32():773-793. PubMed ID: 37346977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive high-throughput screening of PEGylated lipids in oligonucleotide-loaded lipid nanoparticles for neuronal gene silencing.
    Sarode A; Fan Y; Byrnes AE; Hammel M; Hura GL; Fu Y; Kou P; Hu C; Hinz FI; Roberts J; Koenig SG; Nagapudi K; Hoogenraad CC; Chen T; Leung D; Yen CW
    Nanoscale Adv; 2022 May; 4(9):2107-2123. PubMed ID: 36133441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Delivery of Antisense Oligonucleotides Using Bioreducible Lipid Nanoparticles In Vitro and In Vivo.
    Yang L; Ma F; Liu F; Chen J; Zhao X; Xu Q
    Mol Ther Nucleic Acids; 2020 Mar; 19():1357-1367. PubMed ID: 32160706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T7 Peptide-Conjugated Lipid Nanoparticles for Dual Modulation of Bcl-2 and Akt-1 in Lung and Cervical Carcinomas.
    Cheng X; Yu D; Cheng G; Yung BC; Liu Y; Li H; Kang C; Fang X; Tian S; Zhou X; Liu Q; Lee RJ
    Mol Pharm; 2018 Oct; 15(10):4722-4732. PubMed ID: 30138565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fluorescent splice-switching mouse model enables high-throughput, sensitive quantification of antisense oligonucleotide delivery and activity.
    Byrnes AE; Roudnicky F; Gogineni A; Soung AL; Xiong M; Hayne M; Heaster-Ford T; Shatz-Binder W; Dominguez SL; Imperio J; Gierke S; Roberts J; Guo J; Ghosh S; Yu C; Roose-Girma M; Elstrott J; Easton A; Hoogenraad CC
    Cell Rep Methods; 2024 Jan; 4(1):100673. PubMed ID: 38171361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated high-throughput preparation and characterization of oligonucleotide-loaded lipid nanoparticles.
    Fan Y; Yen CW; Lin HC; Hou W; Estevez A; Sarode A; Goyon A; Bian J; Lin J; Koenig SG; Leung D; Nagapudi K; Zhang K
    Int J Pharm; 2021 Apr; 599():120392. PubMed ID: 33639228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of Oligonucleotides Using a Self-Degradable Lipid-Like Material.
    Tanaka H; Takata N; Sakurai Y; Yoshida T; Inoue T; Tamagawa S; Nakai Y; Tange K; Yoshioka H; Maeki M; Tokeshi M; Akita H
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33924589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A physiologically-based pharmacokinetic model to describe antisense oligonucleotide distribution after intrathecal administration.
    Monine M; Norris D; Wang Y; Nestorov I
    J Pharmacokinet Pharmacodyn; 2021 Oct; 48(5):639-654. PubMed ID: 33991294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-cell map of antisense oligonucleotide activity in the brain.
    Mortberg MA; Gentile JE; Nadaf NM; Vanderburg C; Simmons S; Dubinsky D; Slamin A; Maldonado S; Petersen CL; Jones N; Kordasiewicz HB; Zhao HT; Vallabh SM; Minikel EV
    Nucleic Acids Res; 2023 Aug; 51(14):7109-7124. PubMed ID: 37188501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a Quality-By-Design Approach to Optimise Lipid-Polymer Hybrid Nanoparticles Loaded with a Splice-Correction Antisense Oligonucleotide: Maximising Loading and Intracellular Delivery.
    Thanki K; Papai S; Lokras A; Rose F; Falkenberg E; Franzyk H; Foged C
    Pharm Res; 2019 Jan; 36(3):37. PubMed ID: 30623253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic delivery of mutant huntingtin lowering antisense oligonucleotides to the brain using apolipoprotein A-I nanodisks for Huntington disease.
    Caron NS; Aly AE; Findlay Black H; Martin DDO; Schmidt ME; Ko S; Anderson C; Harvey EM; Casal LL; Anderson LM; Rahavi SMR; Reid GSD; Oda MN; Stanimirovic D; Abulrob A; McBride JL; Leavitt BR; Hayden MR
    J Control Release; 2024 Mar; 367():27-44. PubMed ID: 38215984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the Delivery of SOD1 Antisense Oligonucleotides to Motor Neurons Using Calcium Phosphate-Lipid Nanoparticles.
    Chen L; Watson C; Morsch M; Cole NJ; Chung RS; Saunders DN; Yerbury JJ; Vine KL
    Front Neurosci; 2017; 11():476. PubMed ID: 28912673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlating the Structure and Gene Silencing Activity of Oligonucleotide-Loaded Lipid Nanoparticles Using Small-Angle X-ray Scattering.
    Hammel M; Fan Y; Sarode A; Byrnes AE; Zang N; Kou P; Nagapudi K; Leung D; Hoogenraad CC; Chen T; Yen CW; Hura GL
    ACS Nano; 2023 Jun; 17(12):11454-11465. PubMed ID: 37279108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid nanoparticles for antisense oligonucleotide gene interference into brain border-associated macrophages.
    Calero M; Moleiro LH; Sayd A; Dorca Y; Miquel-Rio L; Paz V; Robledo-Montaña J; Enciso E; Acción F; Herráez-Aguilar D; Hellweg T; Sánchez L; Bortolozzi A; Leza JC; García-Bueno B; Monroy F
    Front Mol Biosci; 2022; 9():887678. PubMed ID: 36406277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution visualisation of antisense oligonucleotide release from polymers in cells.
    King JJ; Chen K; Evans CW; Norret M; Almasri R; Pavlos NJ; Hui HY; Lin Q; Bhatt U; Young SG; Smith NM; Nikan M; Prestidge CA; Jiang H; Iyer KS
    Chem Sci; 2024 Aug; 15(38):15690-7. PubMed ID: 39246363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.
    Zhang R; El-Mayta R; Murdoch TJ; Warzecha CC; Billingsley MM; Shepherd SJ; Gong N; Wang L; Wilson JM; Lee D; Mitchell MJ
    Biomater Sci; 2021 Feb; 9(4):1449-1463. PubMed ID: 33404020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid Nanoparticle (LNP) Chemistry Can Endow Unique
    Johnson LT; Zhang D; Zhou K; Lee SM; Liu S; Dilliard SA; Farbiak L; Chatterjee S; Lin YH; Siegwart DJ
    Mol Pharm; 2022 Nov; 19(11):3973-3986. PubMed ID: 36154076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging.
    M Bailey-Hytholt C; Ulinski G; Dugas J; Haines M; Lazebnik M; Piepenhagen P; E Zarraga I; Bandekar A
    Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37016519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified ASO conjugates encapsulated with cytidinyl/cationic lipids exhibit more potent and longer-lasting anti-HCC effects.
    Pan Y; Guan J; Gao Y; Zhu Y; Li H; Guo H; He Q; Guan Z; Yang Z
    Mol Ther Nucleic Acids; 2023 Jun; 32():807-821. PubMed ID: 37251692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.